Inflammation as a Driver of Adverse Left Ventricular Remodeling after Acute Myocardial Infarction

Journal of the American College of Cardiology

Volumn 67, Issue 17, 2016, Pages 2050-2060

  Westman, Peter C ^a   Lipinski, Michael J ^a   Luger, Dror ^a   Waksman, Ron ^a   Bonow, Robert O ^b   Wu, Edwin ^b   Epstein, Stephen E ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

heart failure; infarct size; left ventricular function; stem cells

Indexed keywords

INFLAMMASOME; BIOLOGICAL MARKER; CYTOKINE;

ACUTE HEART INFARCTION; ATHEROSCLEROSIS; AUTOINFLAMMATORY DISEASE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL TRIAL (TOPIC); CYTOKINE RELEASE; DISEASE ASSOCIATION; EXTRACELLULAR MATRIX; GENETIC POLYMORPHISM; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART OUTPUT; HEART VENTRICLE REMODELING; HUMAN; INFECTION; INFLAMMATION; INNATE IMMUNITY; LEUKOCYTE FUNCTION; MESENCHYMAL STEM CELL; NEOVASCULARIZATION (PATHOLOGY); NEUTROPHIL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; TISSUE REPAIR; ANGIOGENESIS; ANTAGONISTS AND INHIBITORS; AUTOIMMUNE DISEASE; CARDIAC MUSCLE; COMPLICATION; HEART INFARCTION; HEART STROKE VOLUME; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; PHYSIOLOGY;

AUTOIMMUNE DISEASES; BIOMARKERS; CYTOKINES; HUMANS; INFECTION; INFLAMMASOMES; INFLAMMATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MYOCARDIAL INFARCTION; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; NEUTROPHILS; POLYMORPHISM, GENETIC; STROKE VOLUME; VENTRICULAR REMODELING;

EID: 84964937531     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.01.073     Document Type: Review

References (80)

1. E.C. Keeley, J.A. Boura, and C.L. Grines Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials Lancet 361 2003 13 20
2. V. Schächinger, B. Assmus, S. Erbs, and et al. Intracoronary infusion of bone marrow-derived mononuclear cells abrogates adverse left ventricular remodelling post-acute myocardial infarction: insights from the Reinfusion of Enriched Progenitor Cells and Infarct Remodelling in Acute Myocardial Infarction (REPAIR-AMI) trial Eur J Heart Fail 11 2009 973 979
3. P. Gaudron, C. Eilles, I. Kugler, and et al. Progressive left ventricular dysfunction and remodeling after myocardial infarction: potential mechanisms and early predictors Circulation 87 1993 755 763
4. R.Y. Kwong, A.K. Chan, K.A. Brown, and et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease Circulation 113 2006 2733 2743
5. E. Wu, J.T. Ortiz, P. Tejedor, and et al. Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study Heart 94 2008 730 736
6. K. Ono, A. Matsumori, T. Shioi, and et al. Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling Circulation 98 1998 149 156
7. M. Bujak, M. Dobaczewski, K. Chatila, and et al. Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling Am J Pathol 173 2008 57 67
8. A. Abbate, F.N. Salloum, E. Vecile, and et al. Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction Circulation 117 2008 2670 2683
9. S. Orn, T. Ueland, C. Manhenke, and et al. Increased interleukin-1β levels are associated with left ventricular hypertrophy and remodelling following acute ST segment elevation myocardial infarction treated by primary percutaneous coronary intervention J Intern Med 272 2012 267 276
10. X. Li, C. Chen, F. Gan, and et al. Plasma NT pro-BNP, hs-CRP and big-ET levels at admission as prognostic markers of survival in hospitalized patients with dilated cardiomyopathy: a single-center cohort study BMC Cardiovasc Disord 14 2014 67
11. A. Deswal, N.J. Petersen, A.M. Feldman, and et al. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST) Circulation 103 2001 2055 2059
12. M. Knorr, T. Münzel, and P. Wenzel Interplay of NK cells and monocytes in vascular inflammation and myocardial infarction Front Physiol 5 2014 295
13. M. Ciz, P. Denev, M. Kratchanova, and et al. Flavonoids inhibit the respiratory burst of neutrophils in mammals Oxid Med Cell Longev 2012 2012 181295
14. N.G. Frangogiannis The inflammatory response in myocardial injury, repair, and remodelling Nat Rev Cardiol 11 2014 255 265
15. P. Christia, and N.G. Frangogiannis Targeting inflammatory pathways in myocardial infarction Eur J Clin Invest 43 2013 986 995
16. T. Anzai Post-infarction inflammation and left ventricular remodeling: a double-edged sword Circ J 77 2013 580 587
17. I.M. Seropian, S. Toldo, B.W. Van Tassell, and et al. Anti-inflammatory strategies for ventricular remodeling following ST-segment elevation acute myocardial infarction J Am Coll Cardiol 63 2014 1593 1603
18. H.F. Weisman, T. Bartow, M.K. Leppo, and et al. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis Science 249 1990 146 151
19. L. Timmers, G. Pasterkamp, V.C. de Hoog, and et al. The innate immune response in reperfused myocardium Cardiovasc Res 94 2012 276 283
20. L. Timmers, J.P. Sluijter, J.K. van Keulen, and et al. Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction Circ Res 102 2008 257 264
21. K. Schroder, and J. Tschopp The inflammasomes Cell 140 2010 821 832
22. H. Fan, B. Sun, Q. Gu, and et al. Oxygen radicals trigger activation of NF-κB and AP-1 and upregulation of ICAM-1 in reperfused canine heart Am J Physiol Heart Circ Physiol 282 2002 H1778 H1786
23. M.C. Territo, T. Ganz, M.E. Selsted, and et al. Monocyte-chemotactic activity of defensins from human neutrophils J Clin Invest 84 1989 2017 2020
24. Y. Zouggari, H. Ait-Oufella, P. Bonnin, and et al. B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction Nat Med 19 2013 1273 1280
25. U. Boehm, T. Klamp, M. Groot, and et al. Cellular responses to interferon-gamma Annu Rev Immunol 15 1997 749 795
26. W.M. Yokoyama, S. Kim, and A.R. French The dynamic life of natural killer cells Annu Rev Immunol 22 2004 405 429
27. B.B. Ayach, M. Yoshimitsu, F. Dawood, and et al. Stem cell factor receptor induces progenitor and natural killer cell-mediated cardiac survival and repair after myocardial infarction Proc Natl Acad Sci U S A 103 2006 2304 2309
28. M. Bouchentouf, K.A. Forner, J. Cuerquis, and et al. Induction of cardiac angiogenesis requires killer cell lectin-like receptor 1 and α4β7 integrin expression by NK cells J Immunol 185 2010 7014 7025
29. N.G. Frangogiannis, L.H. Mendoza, M.L. Lindsey, and et al. IL-10 is induced in the reperfused myocardium and may modulate the reaction to injury J Immunol 165 2000 2798 2808
30. Z. Yang, B. Zingarelli, and C. Szabó Crucial role of endogenous interleukin-10 production in myocardial ischemia/reperfusion injury Circulation 101 2000 1019 1026
31. M. Dobaczewski, W. Chen, and N.G. Frangogiannis Transforming growth factor (TGF)-beta signaling in cardiac remodeling J Mol Cell Cardiol 51 2011 600 606
32. A. Anzai, T. Anzai, S. Nagai, and et al. Regulatory role of dendritic cells in postinfarction healing and left ventricular remodeling Circulation 125 2012 1234 1245
33. F. Andreotti, I. Porto, F. Crea, and et al. Inflammatory gene polymorphisms and ischaemic heart disease: review of population association studies Heart 87 2002 107 112
34. Y. Momiyama, R. Hirano, H. Taniguchi, and et al. Effects of interleukin-1 gene polymorphisms on the development of coronary artery disease associated with Chlamydia pneumoniae infection J Am Coll Cardiol 38 2001 712 717
35. G. Candore, A. Aquino, C.R. Balistreri, and et al. Inflammation, longevity, and cardiovascular diseases: role of polymorphisms of TLR4 Ann N Y Acad Sci 1067 2006 282 287
36. D.A. Enquobahrie, K. Rice, O.D. Williams, and et al. IL1B genetic variation and plasma C-reactive protein level among young adults: the CARDIA study Atherosclerosis 202 2009 513 520
37. B. Meder, F. Rühle, T. Weis, and et al. A genome-wide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy Eur Heart J 35 2014 1069 1077
38. S.L. Masters, A. Simon, I. Aksentijevich, and et al. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease Annu Rev Immunol 27 2009 621 668
39. D.L. Kastner, I. Aksentijevich, and R. Goldbach-Mansky Autoinflammatory disease reloaded: a clinical perspective Cell 140 2010 784 790
40. H. Wen, J.P. Ting, and L.A. O'Neill A role for the NLRP3 inflammasome in metabolic diseases: did Warburg miss inflammation? Nat Immunol 13 2012 352 357
41. S.E. Epstein, J. Zhu, A.H. Najafi, and et al. Insights into the role of infection in atherogenesis and in plaque rupture Circulation 119 2009 3133 3141
42. H.J. Rupprecht, S. Blankenberg, C. Bickel, and et al. Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease Circulation 104 2001 25 31
43. J. Zhu, F.J. Nieto, B.D. Horne, and et al. Prospective study of pathogen burden and risk of myocardial infarction or death Circulation 103 2001 45 51
44. D. Rott, J. Zhu, M.S. Burnett, and et al. Serum of cytomegalovirus-infected mice induces monocyte chemoattractant protein-1 expression by endothelial cells J Infect Dis 184 2001 1109 1113
45. D. Rott, J. Zhu, Y.F. Zhou, and et al. IL-6 is produced by splenocytes derived from CMV-infected mice in response to CMV antigens, and induces MCP-1 production by endothelial cells: a new mechanistic paradigm for infection-induced atherogenesis Atherosclerosis 170 2003 223 228
46. J.W. McEvoy, K. Nasir, A.P. DeFilippis, and et al. Relationship of cigarette smoking with inflammation and subclinical vascular disease: the Multi-Ethnic Study of Atherosclerosis Arterioscler Thromb Vasc Biol 35 2015 1002 1010
47. F. Samad, and W. Ruf Inflammation, obesity, and thrombosis Blood 122 2013 3415 3422
48. J.M. Munro, and R.S. Cotran The pathogenesis of atherosclerosis: atherogenesis and inflammation Lab Invest 58 1988 249 261
49. E. Lontchi-Yimagou, E. Sobngwi, T.E. Matsha, and et al. Diabetes mellitus and inflammation Curr Diab Rep 13 2013 435 444
50. Heart Outcomes Prevention Evaluation Study investigators Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients N Engl J Med 342 2000 145 153
51. P.M. Ridker, M. Cushman, M.J. Stampfer, and et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men [published correction appears in N Engl J Med 1997;337:356] N Engl J Med 336 1997 973 979
52. D. Tousoulis, C. Psarros, M. Demosthenous, and et al. Innate and adaptive inflammation as a therapeutic target in vascular disease: the emerging role of statins J Am Coll Cardiol 63 2014 2491 2502
53. Y. Ma, A. Yabluchanskiy, and M.L. Lindsey Neutrophil roles in left ventricular remodeling following myocardial infarction Fibrogenesis Tissue Repair 6 2013 11
54. T. Aversano, W. Zhou, M. Nedelman, and et al. A chimeric IgG4 monoclonal antibody directed against CD18 reduces infarct size in a primate model of myocardial ischemia and reperfusion J Am Coll Cardiol 25 1995 781 788
55. A.J. Palazzo, S.P. Jones, W.G. Girod, and et al. Myocardial ischemia-reperfusion injury in CD18- and ICAM-1-deficient mice Am J Physiol 275 1998 H2300 H2307
56. K.W. Baran, M. Nguyen, G.R. McKendall, and et al. Double-blind, randomized trial of an anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for acute myocardial infarction: limitation of myocardial infarction following thrombolysis in acute myocardial infarction (LIMIT AMI) study Circulation 104 2001 2778 2783
57. D.P. Faxon, R.J. Gibbons, N.A. Chronos, and et al. The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study J Am Coll Cardiol 40 2002 1199 1204
58. J.M. Rusnak, S.L. Kopecky, I.P. Clements, and et al. An anti-CD11/CD18 monoclonal antibody in patients with acute myocardial infarction having percutaneous transluminal coronary angioplasty (the FESTIVAL study) Am J Cardiol 88 2001 482 487
59. D.L. Mann, J.J. McMurray, M. Packer, and et al. Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL) Circulation 109 2004 1594 1602
60. C.J. Fisher Jr., J.M. Agosti, S.M. Opal, and et al. Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group N Engl J Med 334 1996 1697 1702
61. T.L. Michaud, Y.H. Rho, T. Shamliyan, and et al. The comparative safety of tumor necrosis factor inhibitors in rheumatoid arthritis: a meta-analysis update of 44 trials Am J Med 127 2014 1208 1232
62. B.W. Van Tassell, S. Toldo, E. Mezzaroma, and et al. Targeting interleukin-1 in heart disease Circulation 128 2013 1910 1923
63. A. Abbate, M.C. Kontos, J.D. Grizzard, and et al. Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot study) Am J Cardiol 105 2010 1371 1377.e1
64. A. Abbate, B.W. Van Tassell, G. Biondi-Zoccai, and et al. Effects of interleukin-1 blockade with anakinra on adverse cardiac remodeling and heart failure after acute myocardial infarction (from the Virginia Commonwealth University-Anakinra Remodeling Trial [2] [VCU-ART2] pilot study) Am J Cardiol 111 2013 1394 1400
65. Virginia Commonwealth University. Interleukin-1 (IL-1) Blockade in Acute Myocardial Infarction (VCU-ART3). 2015. Available at: https://clinicaltrials.gov/ct2/show/study/NCT01950299. Accessed February 22, 2016.
66. M. Takahashi NLRP3 inflammasome as a novel player in myocardial infarction Int Heart J 55 2014 101 105
67. S. Toldo, E. Mezzaroma, A.G. Mauro, and et al. The inflammasome in myocardial injury and cardiac remodeling Antioxid Redox Signal 22 2015 1146 1161
68. S. Aggarwal, and M.F. Pittenger Human mesenchymal stem cells modulate allogeneic immune cell responses Blood 105 2005 1815 1822
69. M. Gazdic, V. Volarevic, N. Arsenijevic, and et al. Mesenchymal stem cells: a friend or foe in immune-mediated diseases Stem Cell Rev 11 2015 280 287
70. M. Ayatollahi, Z. Hesami, A. Jamshidzadeh, and et al. Antioxidant effects of bone marrow mesenchymal stem cell against carbon tetrachloride-induced oxidative damage in rat livers Int J Organ Transplant Med 5 2014 166 173
71. G. Jin, G. Qiu, D. Wu, and et al. Allogeneic bone marrow-derived mesenchymal stem cells attenuate hepatic ischemia-reperfusion injury by suppressing oxidative stress and inhibiting apoptosis in rats Int J Mol Med 31 2013 1395 1401
72. A. Eirin, X.Y. Zhu, B. Ebrahimi, and et al. Intra-renal delivery of mesenchymal stem cells and endothelial progenitor cells attenuates hypertensive cardiomyopathy in experimental renovascular hypertension Cell Transplant 24 2015 2041 2053
73. T.P. Lozito, W.M. Jackson, L.J. Nesti, and et al. Human mesenchymal stem cells generate a distinct pericellular zone of MMP activities via binding of MMPs and secretion of high levels of TIMPs Matrix Biol 34 2014 132 143
74. T.P. Lozito, and R.S. Tuan Mesenchymal stem cells inhibit both endogenous and exogenous MMPs via secreted TIMPs J Cell Physiol 226 2011 385 396
75. M. Gnecchi, Z. Zhang, A. Ni, and et al. Paracrine mechanisms in adult stem cell signaling and therapy Circ Res 103 2008 1204 1219
76. C.W. Lee, E. Stabile, T. Kinnaird, and et al. Temporal patterns of gene expression after acute hindlimb ischemia in mice: insights into the genomic program for collateral vessel development J Am Coll Cardiol 43 2004 474 482
77. T. Kinnaird, E. Stabile, M.S. Burnett, and et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms Circ Res 94 2004 678 685
78. H. Kamihata, H. Matsubara, T. Nishiue, and et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines Circulation 104 2001 1046 1052
79. D.M. Clifford, S.A. Fisher, S.J. Brunskill, and et al. Stem cell treatment for acute myocardial infarction Cochrane Database Syst Rev 2 2012 CD006536
80. M.R. Rosen, R.J. Myerburg, D.P. Francis, and et al. Translating stem cell research to cardiac disease therapies: pitfalls and prospects for improvement J Am Coll Cardiol 64 2014 922 937